Form 4: Natera Executive Sells Shares for Tax Obligations Under Pre-Arranged Plan
Insider Transaction Report
Natera's President of Clinical Diagnostics, Solomon Moshkevich, sold shares totaling approximately $299,096 to cover tax withholding obligations related to RSU vesting.
Summary
- Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), reported two sales of common stock.
- On May 27, 2025, 1,649 shares were sold at a price of $156.8505 per share, totaling approximately $258,566.80.
- On July 21, 2025, an additional 291 shares were sold at a price of $139.29 per share, totaling approximately $40,529.79.
- Both sales were executed to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).
- The transactions were made pursuant to written instructions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
- Following the May 27, 2025 transaction, Solomon Moshkevich beneficially owned 128,556 shares.
- Following the July 21, 2025 transaction, Solomon Moshkevich beneficially owned 128,265 shares.
Sentiment
Score: 5
Explanation: Neutral. The sales are routine, non-discretionary transactions to cover tax obligations from RSU vesting, executed under a Rule 10b5-1 plan. This is a common practice and does not typically signal a change in management's view of the company's prospects.
Positives
- The sales were pre-planned under Rule 10b5-1(c), indicating they were not discretionary sales based on new, non-public information.
- The sales were specifically for tax withholding obligations related to RSU vesting, which is a common and routine practice for executives receiving equity compensation.
Negatives
- The transactions result in a reduction of direct insider ownership in Natera, Inc.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Management Comments
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Industry Context
This Form 4 filing details routine insider stock transactions for tax purposes, which is a common occurrence across all industries for executives receiving equity compensation. It does not provide specific insights into broader industry trends or competitive dynamics.
Stakeholder Impact
- Minor impact on shareholders due to a slight reduction in insider ownership, but the nature of the sale (tax-related) under a pre-arranged plan mitigates negative interpretation.
Key Dates
| Date | Description |
|---|---|
| January 28, 2022 | Grant date of Stock Unit Agreement related to the 291 shares sold on July 21, 2025. |
| June 10, 2022 | Grant date of Stock Unit Agreement related to the 1,649 shares sold on May 27, 2025. |
| 05/27/2025 | Sale of 1,649 shares of Natera Common Stock by Solomon Moshkevich. |
| 07/21/2025 | Sale of 291 shares of Natera Common Stock by Solomon Moshkevich. |
| 07/22/2025 | Signature date of the Form 4 filing. |
Keywords
Natera, NTRA, Form 4, Insider Trading, Stock Sale, RSU, Rule 10b5-1, Tax Withholding, Solomon Moshkevich
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.